Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis
NCT04032743 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-10-22
Summary
Children treated with intensive chemotherapy are at increased risk for life-threatening infections (sepsis). As the survival of oncology patients increased with the use of aggressive treatment protocols, there was also an increase in the need for hospitalization in intensive care units (ICU) due to sepsis.Several prognostic factors are known to affect the survival of these patients, including the number and type of damaged systems, the type of oncology disease and the duration of neutropenia. With the development of the treatment of ICU, the survival of the oncology patients hospitalized for sepsis has also increased.
We will collect demographic details, details of their oncology and infections, laboratory tests and imaging. The goal is to identify prognostic factors in oncologic children hospitalized in ICU due to sepsis, as well as clinical and laboratory parameters that characterize this group of patients.
Conditions
- Oncologic Complications and Emergencies
- ICU
- Sepsis
- Childhood Cancer
Interventions
- OTHER
-
ICU treatment
any treatment available by ICU
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Shlomit Barzilai Birenboim, MD · Schneider Children's Medical Center in Israel
Eligibility
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-16
- Primary Completion
- 2022-07-31
- Completion
- 2022-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
NCT06184009 ·Status: RECRUITING ·Phase: PHASE2
-
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
NCT03686566 ·Status: COMPLETED
-
SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia
NCT02324231 ·Status: COMPLETED ·Phase: NA
-
Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
NCT02675166 ·Status: COMPLETED
-
Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
NCT02509234 ·Status: UNKNOWN
-
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
NCT06235125 ·Status: RECRUITING ·Phase: PHASE1
-
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
NCT00566566 ·Status: UNKNOWN
-
A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
NCT04478292 ·Status: RECRUITING ·Phase: PHASE3
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
NCT01944982 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
NCT00334854 ·Status: UNKNOWN ·Phase: PHASE3
-
Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
NCT00003801 ·Status: COMPLETED ·Phase: NA
-
Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity
NCT01533779 ·Status: UNKNOWN
-
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
NCT02756845 ·Status: COMPLETED ·Phase: PHASE1
-
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
NCT01329471 ·Status: UNKNOWN
-
Intra-arterial Chemotherapy for Children With Retinoblastoma
NCT00906113 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Quality of Life in Children Cured of Retinoblastoma
NCT00278031 ·Status: UNKNOWN
-
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04320888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment
NCT05774990 ·Status: COMPLETED
-
Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
NCT01688752 ·Status: WITHDRAWN
-
Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids
NCT04593745 ·Status: UNKNOWN ·Phase: NA
-
Oxaliplatin for Children With Solid Tumors
NCT01558453 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
NCT01974479 ·Status: SUSPENDED ·Phase: PHASE1
-
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
NCT02933333 ·Status: UNKNOWN ·Phase: PHASE4
-
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
NCT03015844 ·Status: AVAILABLE